Extensively drug-resistant acinetobacter baumannii nosocomial pneumonia successfully treated with a novel antibiotic combination

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Extremely drug-resistant (XDR) Acinetobacter baumannii causes challenging nosocomial infections. We report the case of a patient with XDR A. baumannii pneumonia and septic shock successfully treated with cefiderocol and a novel antibiotic obtained via expanded access protocol. With focused research and drug development efforts, the poor outcomes associated with these infections may be mitigated.

Original languageEnglish (US)
Article numbere00924-21
JournalAntimicrobial agents and chemotherapy
Volume65
Issue number11
DOIs
StatePublished - Nov 2021

Keywords

  • Acinetobacter baumanii
  • Antibiotic resistance
  • Antimicrobial agents
  • Beta-lactamases
  • Beta-lactams
  • Durlobactam
  • Gram-negative bacteria
  • Gram-negative resistance
  • Nosocomial infections
  • Novel antibiotics
  • Sulbactam-durlobactam

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Extensively drug-resistant acinetobacter baumannii nosocomial pneumonia successfully treated with a novel antibiotic combination'. Together they form a unique fingerprint.

Cite this